| (210) | Number of the EPO application | 18720834 |
| (220) | Filing date of the EPO application | 2018.04.04 |
| (80) | EPO patent specification publication (B) | EPB nr. 28/2023, 2023.07.12 |
| (110) | EPO patent number | 3609920 |
| (21) | Number of the application | e 2020 0189 |
| (71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US;
Zymeworks BC Inc., CA; |
| (72) | Name(s) of inventor(s), code of the country | D'ANGELO Igor Edmondo Paolo, CA;
LI Yiwen, US;
LUDWIG Dale Lincoln, US;
SHEN Yang, US;
ZHANG Yi, US; |
| (73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US;
Zymeworks BC Inc., CA; |
| (54) | Title of the invention | ANTI-PD-L1-ANTI-TIM-3 BISPECIFIC ANTIBODIES |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.03.31 |
| (30) | Priority | 201762484025 P, 2017.04.11, US |
| (86) | International application | PCT/US2018/026060, 2018.04.04 |
| (87) | International publication | WO 2018/191074, 2018.10.18 |